ERBB2 and breast carcinoma: In recent years, precision treatment has made tremendous improvements in certain kinds of cancer37, such as breast cancer and lung cancer, and prognosis biological indicators, such as estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER-2), have been deeply investigated as well38.